October 1st 2026
Some 27 products have been added to the Discount Not Deducted list on 1 October 2026. : Dispensing GPs cannot take advantage of the DND concession, and clawback will be applied. The DND additions are: Apixaban 1mg/1ml oral suspension s
Dispensary guidance news Pharmacy Owners' News
October 1st 2026
The Department of Health and Social Care has published an eighth update to the initial list of September concessions. This update adds 31 prices and increases one. This brings the total number of September concessions to 246. In addition, Com
Dispensary guidance news DM Zone news
October 1st 2026
NHS England has published the October feescale. From October 1, the scale is as follows: From 1 October 2026, fees are up 3.39 per cent compared to April 2026 and up 0.5 per cent, compared to October 2025. Fees will fall by just
DM Zone news England Wales
October 1st 2026
New pharmaceutical services regulations, taking effect today (Oct 1) will speed up additional premises decisions, the DDA 2026 conference heard. In the first in a new series of breakout sessions at the DDA 2026 Conference, delegates were told about
Conference news DDA news
September 30th 2026
Potential changes to the dispensing fee payment framework will be discussed by the DDA as the Health Bill progresses through Parliament, the DDA 2026 conference has heard. Opening the conference, the DDA Chairman and DDA regional chairs ex
Conference news DDA news
September 28th 2026
From 1 October, changes in Category M reimbursement prices will reflect: Adjustments for underlying market price movements during the quarter April-June 2026 (Q1 2026/27) An upwards adjustment to medicine margin by £14.5 million per quarter
Drug Tariff Updates
September 28th 2026
BMA Wales has called for reform of the funding and support arrangements for dispensing practices in its third ‘Save Our Surgeries’ report. The report makes three specific recommendations for dispensing practices in Wales, reflectin
Political News Wales
NHS digitisation/electronic prescription services 
Pharmaceutical Needs Assessments 
Reimbursement 
Clawback 
Branded generics 
Remuneration - rurality 
